Opus Genetics, Inc. - IRD
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G | Balyasny Asset Management L.P. | 7.41% | 5,110,373 | View |
| Feb 17, 2026 | SCHEDULE 13G | BAM GP LLC | 7.41% | 5,110,373 | View |
| Feb 17, 2026 | SCHEDULE 13G | Balyasny Asset Management Holdings LP | 7.41% | 5,110,373 | View |
| Feb 17, 2026 | SCHEDULE 13G | Dames GP LLC | 7.41% | 5,110,373 | View |
| Feb 17, 2026 | SCHEDULE 13G | Dmitry Balyasny | 7.41% | 5,110,373 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 7,174,154 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 7,174,154 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 7,174,154 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Nantahala Capital Management, LLC | 9.99% | 7,123,506 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Wilmot B. Harkey | 9.99% | 7,123,506 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Daniel Mack | 9.99% | 7,123,506 | View |
| Dec 11, 2025 | SCHEDULE 13D/A | — | 8.0% | — | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.